The biotech scene, although volatile, will continue to provide jobs. But potential employees should prepare for a bumpy ride, say Paul Smaglik and Adam Smith.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smaglik, P., Smith, A. Riding the biotech rollercoaster. Nature 418, 4–5 (2002). https://doi.org/10.1038/nj6893-04a
Issue date:
DOI: https://doi.org/10.1038/nj6893-04a
This article is cited by
-
Back to basics: from industry to academia
Nature (2004)